These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
507 related articles for article (PubMed ID: 11927615)
1. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. Kabashima K; Saji T; Murata T; Nagamachi M; Matsuoka T; Segi E; Tsuboi K; Sugimoto Y; Kobayashi T; Miyachi Y; Ichikawa A; Narumiya S J Clin Invest; 2002 Apr; 109(7):883-93. PubMed ID: 11927615 [TBL] [Abstract][Full Text] [Related]
2. Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment. Jiang GL; Im WB; Donde Y; Wheeler LA J Pharmacol Exp Ther; 2010 Dec; 335(3):546-52. PubMed ID: 20833794 [TBL] [Abstract][Full Text] [Related]
3. The prevention of colitis by E Prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration. Jiang GL; Nieves A; Im WB; Old DW; Dinh DT; Wheeler L J Pharmacol Exp Ther; 2007 Jan; 320(1):22-8. PubMed ID: 17008451 [TBL] [Abstract][Full Text] [Related]
5. Role of EP4 receptor and prostaglandin transporter in prostaglandin E2-induced alteration in colonic epithelial barrier integrity. Lejeune M; Leung P; Beck PL; Chadee K Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1097-105. PubMed ID: 20813914 [TBL] [Abstract][Full Text] [Related]
6. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis. Chu CC; Hou YC; Pai MH; Chao CJ; Yeh SL J Nutr Biochem; 2012 Sep; 23(9):1092-9. PubMed ID: 22137260 [TBL] [Abstract][Full Text] [Related]
7. Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329. Nitta M; Hirata I; Toshina K; Murano M; Maemura K; Hamamoto N; Sasaki S; Yamauchi H; Katsu K Scand J Immunol; 2002 Jul; 56(1):66-75. PubMed ID: 12100473 [TBL] [Abstract][Full Text] [Related]
8. Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis. Esaki Y; Li Y; Sakata D; Yao C; Segi-Nishida E; Matsuoka T; Fukuda K; Narumiya S Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12233-8. PubMed ID: 20566843 [TBL] [Abstract][Full Text] [Related]
9. E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2. Okano M; Sugata Y; Fujiwara T; Matsumoto R; Nishibori M; Shimizu K; Maeda M; Kimura Y; Kariya S; Hattori H; Yokoyama M; Kino K; Nishizaki K Immunology; 2006 Jul; 118(3):343-52. PubMed ID: 16827895 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic effects of Lonicera japonica extract on dextran sulphate sodium-induced colitis in a mouse model by the inhibition of the Th1/Th17 response. Park JW; Bae H; Lee G; Hong BG; Yoo HH; Lim SJ; Lee K; Kim J; Ryu B; Lee BJ; Bae J; Lee H; Bu Y Br J Nutr; 2013 Jan; 109(2):283-92. PubMed ID: 22569277 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E receptor EP4 stimulates lymphangiogenesis to promote mucosal healing during DSS-induced colitis. Hosono K; Kojo K; Narumiya S; Majima M; Ito Y Biomed Pharmacother; 2020 Aug; 128():110264. PubMed ID: 32447215 [TBL] [Abstract][Full Text] [Related]
12. Prevention of trinitrobenzene sulfonic acid-induced experimental colitis by oral administration of a poly(lactic-coglycolic acid) microsphere containing prostaglandin E₂ receptor subtype 4 agonist. Okamoto T; Uemoto S; Tabata Y J Pharmacol Exp Ther; 2012 May; 341(2):340-9. PubMed ID: 22300734 [TBL] [Abstract][Full Text] [Related]
13. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome. Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development. Shoji Y; Takahashi M; Kitamura T; Watanabe K; Kawamori T; Maruyama T; Sugimoto Y; Negishi M; Narumiya S; Sugimura T; Wakabayashi K Gut; 2004 Aug; 53(8):1151-8. PubMed ID: 15247185 [TBL] [Abstract][Full Text] [Related]
15. Effects of prostanoid EP agonists on mouse intraocular pressure. Saeki T; Ota T; Aihara M; Araie M Invest Ophthalmol Vis Sci; 2009 May; 50(5):2201-8. PubMed ID: 19117925 [TBL] [Abstract][Full Text] [Related]
16. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice. Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649 [TBL] [Abstract][Full Text] [Related]
17. Endogenous prostaglandin E2 accelerates healing of indomethacin-induced small intestinal lesions through upregulation of vascular endothelial growth factor expression by activation of EP4 receptors. Takeuchi K; Tanigami M; Amagase K; Ochi A; Okuda S; Hatazawa R J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S67-74. PubMed ID: 20586869 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation. Iwanaga K; Okada M; Murata T; Hori M; Ozaki H J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372 [TBL] [Abstract][Full Text] [Related]
19. Regulation of gut inflammation and th17 cell response by interleukin-21. Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085 [TBL] [Abstract][Full Text] [Related]
20. Involvement of prostaglandin E receptor EP3 subtype in duodenal bicarbonate secretion in rats. Aihara E; Nomura Y; Sasaki Y; Ise F; Kita K; Takeuchi K Life Sci; 2007 Jun; 80(26):2446-53. PubMed ID: 17512019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]